JP2009503104A5 - - Google Patents

Download PDF

Info

Publication number
JP2009503104A5
JP2009503104A5 JP2008525187A JP2008525187A JP2009503104A5 JP 2009503104 A5 JP2009503104 A5 JP 2009503104A5 JP 2008525187 A JP2008525187 A JP 2008525187A JP 2008525187 A JP2008525187 A JP 2008525187A JP 2009503104 A5 JP2009503104 A5 JP 2009503104A5
Authority
JP
Japan
Prior art keywords
composition
modified nanoparticles
solid material
powder
bulk solid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008525187A
Other languages
English (en)
Japanese (ja)
Other versions
JP5694643B2 (ja
JP2009503104A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/030278 external-priority patent/WO2007019229A1/en
Publication of JP2009503104A publication Critical patent/JP2009503104A/ja
Publication of JP2009503104A5 publication Critical patent/JP2009503104A5/ja
Application granted granted Critical
Publication of JP5694643B2 publication Critical patent/JP5694643B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2008525187A 2005-08-05 2006-08-04 改善された流動性を示す組成物 Expired - Fee Related JP5694643B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US70582105P 2005-08-05 2005-08-05
US60/705,821 2005-08-05
PCT/US2006/030278 WO2007019229A1 (en) 2005-08-05 2006-08-04 Compositions exhibiting improved flowability

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013027433A Division JP2013100352A (ja) 2005-08-05 2013-02-15 改善された流動性を示す組成物

Publications (3)

Publication Number Publication Date
JP2009503104A JP2009503104A (ja) 2009-01-29
JP2009503104A5 true JP2009503104A5 (enExample) 2009-09-24
JP5694643B2 JP5694643B2 (ja) 2015-04-01

Family

ID=37311861

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008525187A Expired - Fee Related JP5694643B2 (ja) 2005-08-05 2006-08-04 改善された流動性を示す組成物
JP2013027433A Pending JP2013100352A (ja) 2005-08-05 2013-02-15 改善された流動性を示す組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013027433A Pending JP2013100352A (ja) 2005-08-05 2013-02-15 改善された流動性を示す組成物

Country Status (7)

Country Link
US (1) US8062670B2 (enExample)
EP (1) EP1917301B1 (enExample)
JP (2) JP5694643B2 (enExample)
CN (1) CN101243130B (enExample)
AU (1) AU2006278571B2 (enExample)
CA (1) CA2617909C (enExample)
WO (1) WO2007019229A1 (enExample)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
EP1494732B1 (en) 2002-03-20 2008-01-30 MannKind Corporation Inhalation apparatus
US7638138B2 (en) * 2003-02-21 2009-12-29 Translational Research, Ltd. Compositions for nasal administration of pharmaceuticals
WO2004087243A1 (ja) 2003-03-27 2004-10-14 Bioactis Limited 鼻腔用粉末薬剤施薬装置
WO2006016530A1 (ja) * 2004-08-10 2006-02-16 Translational Research, Ltd. 速効性でかつ高い吸収性を可能とする経鼻投与用組成物
DK1786784T3 (da) 2004-08-20 2011-02-14 Mannkind Corp Katalyse af diketopiperazinsyntese
CN104436170B (zh) 2004-08-23 2018-02-23 曼金德公司 用于药物输送的二酮哌嗪盐
AU2006290227B2 (en) 2005-09-14 2012-08-02 Mannkind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
KR20080096809A (ko) 2006-02-22 2008-11-03 맨카인드 코포레이션 디케토피페라진 및 활성제를 포함하는 마이크로입자의 약학특성의 개선 방법
US20080071141A1 (en) * 2006-09-18 2008-03-20 Abhisuek Gattani Method and apparatus for measuring attributes of an anatomical feature during a medical procedure
EP2104714A1 (en) * 2006-12-21 2009-09-30 3M Innovative Properties Company Process for producing nanoparticles
ES2652415T3 (es) * 2006-12-26 2018-02-02 Shin Nippon Biomedical Laboratories, Ltd. Preparación para aplicación transnasal
CN101113078B (zh) * 2007-07-10 2011-02-02 程道远 新型玻璃防霉隔离粉
EP2242804A1 (en) * 2007-12-21 2010-10-27 3M Innovative Properties Company Mixed ligand surface-modified nanoparticles
DE102008020701A1 (de) * 2008-04-24 2009-10-29 Bayer Technology Services Gmbh Formulierung mit reduzierter Hygroskopizität
US8404876B2 (en) * 2008-05-08 2013-03-26 3M Innovative Properties Company Process for producing nanoparticles
EP2296628B1 (en) * 2008-05-22 2014-05-14 3M Innovative Properties Company Process for manufacturing flowable powder drug compositions
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
SG10201507036TA (en) 2008-06-13 2015-10-29 Mannkind Corp A dry powder inhaler and system for drug delivery
EP2609954B1 (en) 2008-06-20 2021-12-29 MannKind Corporation An interactive apparatus for real-time profiling of inhalation efforts
WO2009158300A1 (en) 2008-06-26 2009-12-30 3M Innovative Properties Company Dry powder pharmaceutical compositions for pulmonary administration, and methods of manufacturing thereof
WO2010002613A2 (en) * 2008-07-02 2010-01-07 3M Innovative Properties Company Method of making a dry powder pharmaceutical composition
TWI614024B (zh) 2008-08-11 2018-02-11 曼凱公司 超快起作用胰島素之用途
US20100116172A1 (en) * 2008-11-13 2010-05-13 3M Innovative Properties Company Method for making a dispersion
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
WO2010077773A1 (en) * 2008-12-30 2010-07-08 3M Innovative Properties Company Lubricant composition and method of forming
WO2010077583A1 (en) 2008-12-30 2010-07-08 3M Innovative Properties Company Composite particles and method of forming
MX2011009512A (es) 2009-03-11 2011-11-29 Mannkind Corp Aparato, sistema y metodo para medir la resistencia de un inhalador.
EP2429495A4 (en) 2009-05-15 2014-01-22 Shin Nippon Biomedical Lab Ltd INTRANASAL PHARMACEUTICAL COMPOSITION WITH IMPROVED PHARMACOKINETICS
MY157166A (en) 2009-06-12 2016-05-13 Mankind Corp Diketopiperazine microparticles with defined specific surface areas
US20100323067A1 (en) * 2009-06-19 2010-12-23 Hershey Foods Corporation Temperature resistant chocolate composition and method
WO2010151435A1 (en) 2009-06-26 2010-12-29 3M Innovative Properties Company Method of milling particles with nanoparticles and milled free-flowing powder
GB2472327B (en) 2009-07-31 2013-03-13 Shin Nippon Biomedical Lab Ltd Intranasal granisetron and nasal applicator
CA2778698A1 (en) 2009-11-03 2011-05-12 Mannkind Corporation An apparatus and method for simulating inhalation efforts
JP5690352B2 (ja) 2009-11-20 2015-03-25 スリーエム イノベイティブ プロパティズ カンパニー 表面修飾ナノ粒子が共有結合した導電性粒子を含む組成物及びその製造方法
JP6234678B2 (ja) 2009-11-20 2017-11-22 スリーエム イノベイティブ プロパティズ カンパニー 表面改質ナノ粒子を含む無機顔料組成物及び製造方法
SG181046A1 (en) 2009-12-03 2012-07-30 3M Innovative Properties Co Method of electrostatic deposition of particles, abrasive grain and articles
US8834618B2 (en) 2009-12-03 2014-09-16 3M Innovative Properties Company Method of inhibiting water adsorption of powder by addition of hydrophobic nanoparticles
IL223742A (en) 2010-06-21 2016-06-30 Mannkind Corp A dry powder inhaler and preparation for it
EP2625135B1 (en) 2010-10-04 2017-08-02 3M Innovative Properties Company Method of modifying dissolution rate of particles by addition of hydrophobic nanoparticles
WO2012082536A2 (en) * 2010-12-17 2012-06-21 3M Innovative Properties Company Transfer article having multi-sized particles and methods
EP2694402B1 (en) 2011-04-01 2017-03-22 MannKind Corporation Blister package for pharmaceutical cartridges
CN102810377A (zh) * 2011-05-31 2012-12-05 深圳出入境检验检疫局食品检验检疫技术中心 一种复合型磁性纳米的制备方法及在小分子提取及富集中的应用
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
HK1200318A1 (en) 2011-10-24 2015-08-07 曼金德公司 Methods and compositions for treating pain
US9763965B2 (en) 2012-04-13 2017-09-19 Glaxosmithkline Intellectual Property Development Limited Aggregate particles
EP2872205B1 (en) 2012-07-12 2017-02-08 MannKind Corporation Dry powder drug delivery systems
US10159644B2 (en) 2012-10-26 2018-12-25 Mannkind Corporation Inhalable vaccine compositions and methods
WO2014074797A1 (en) * 2012-11-09 2014-05-15 Civitas Therapeutics, Inc. Ultra low density pulmonary powders
WO2014144895A1 (en) 2013-03-15 2014-09-18 Mannkind Corporation Microcrystalline diketopiperazine compositions and methods
KR102465025B1 (ko) 2013-07-18 2022-11-09 맨카인드 코포레이션 열-안정성 건조 분말 약제학적 조성물 및 방법
EP3030294B1 (en) 2013-08-05 2020-10-07 MannKind Corporation Insufflation apparatus
WO2015044782A2 (en) 2013-09-24 2015-04-02 Shin Nippon Biomedical Laboratories, Ltd. Intranasal dhe for the treatment of headache
CN104644618A (zh) * 2013-11-19 2015-05-27 上海医药工业研究院 一种干粉吸入剂及其制备方法
WO2015095372A1 (en) * 2013-12-19 2015-06-25 3M Innovative Properties Company Nanoparticle powder composition and method of making the same
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
JP6546386B2 (ja) * 2014-10-15 2019-07-17 株式会社アドマテックス 無機フィラー及びその製造方法、樹脂組成物、及び成形品
WO2016064405A1 (en) 2014-10-23 2016-04-28 3M Innovative Properties Company Composition of an insulating pvc substrate with nanoparticle treated filler
KR102406867B1 (ko) 2016-06-16 2022-06-13 쓰리엠 이노베이티브 프로퍼티즈 컴파니 나노입자 충전된 배리어 접착제 조성물
TWI617533B (zh) 2016-12-09 2018-03-11 財團法人工業技術研究院 表面改質陶瓷粉體及其應用
CA3067368A1 (en) 2017-06-16 2018-12-20 TenEx Technologies, LLC Compositions and methods for treating subterranean formations
US11744967B2 (en) 2017-09-26 2023-09-05 Shin Nippon Biomedical Laboratories, Ltd. Intranasal delivery devices
AU2019216929C1 (en) * 2018-02-06 2025-01-30 Nisshin Seifun Welna Inc. Potato starch and potato starch composition
US11820844B2 (en) 2018-03-22 2023-11-21 3M Innovative Properties Company Charge-modified particles and methods of making the same
CN111886216A (zh) 2018-03-22 2020-11-03 3M创新有限公司 改性的氮化铝粒子及其制备方法
EP3893877A4 (en) 2018-12-11 2022-09-14 Satsuma Pharmaceuticals, Inc. COMPOSITIONS, DEVICES AND METHODS FOR TREATMENT OR PREVENTION OF HEADACHE
EP3785825A1 (en) 2019-08-30 2021-03-03 3M Innovative Properties Company Powder blend for use in additive manufacturing
CN111358773B (zh) * 2020-04-10 2021-03-30 广州南鑫药业有限公司 一种帕拉米韦干粉吸入剂及其制备方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2801185A (en) 1952-05-16 1957-07-30 Du Pont Silica hydrosol powder
US4478876A (en) 1980-12-18 1984-10-23 General Electric Company Process of coating a substrate with an abrasion resistant ultraviolet curable composition
US4491508A (en) 1981-06-01 1985-01-01 General Electric Company Method of preparing curable coating composition from alcohol, colloidal silica, silylacrylate and multiacrylate monomer
US4455205A (en) 1981-06-01 1984-06-19 General Electric Company UV Curable polysiloxane from colloidal silica, methacryloyl silane, diacrylate, resorcinol monobenzoate and photoinitiator
US4486504A (en) 1982-03-19 1984-12-04 General Electric Company Solventless, ultraviolet radiation-curable silicone coating compositions
US4522958A (en) 1983-09-06 1985-06-11 Ppg Industries, Inc. High-solids coating composition for improved rheology control containing chemically modified inorganic microparticles
US4767726A (en) 1987-01-12 1988-08-30 Minnesota Mining And Manufacturing Company Glass microbubbles
GB9001635D0 (en) * 1990-01-24 1990-03-21 Ganderton David Aerosol carriers
US5037579A (en) 1990-02-12 1991-08-06 Nalco Chemical Company Hydrothermal process for producing zirconia sol
US5258225A (en) 1990-02-16 1993-11-02 General Electric Company Acrylic coated thermoplastic substrate
AU701603B2 (en) 1994-04-25 1999-02-04 Minnesota Mining And Manufacturing Company Compositions comprising fused particulates and methods of making them
DE19616781A1 (de) 1996-04-26 1997-11-06 Degussa Silanisierte Kieselsäure
HUP0100433A3 (en) 1997-12-22 2003-01-28 Schering Corp Orally administrable solid ribavirin dosage forms and process for producing them
US6329058B1 (en) 1998-07-30 2001-12-11 3M Innovative Properties Company Nanosize metal oxide particles for producing transparent metal oxide colloids and ceramers
GB9822523D0 (en) * 1998-10-15 1998-12-09 Courtaulds Coatings Holdings Powder coating compositions
GB9827145D0 (en) * 1998-12-09 1999-02-03 Co Ordinated Drug Dev Improvements in or relating to powders
US6585957B1 (en) * 2000-01-25 2003-07-01 Aeropharm Technology Incorporated Medicinal aerosol formulation
US7758888B2 (en) * 2000-04-21 2010-07-20 Sol-Gel Technologies Ltd. Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
AU2211502A (en) * 2000-11-30 2002-06-11 Vectura Ltd Method of making particles for use in a pharmaceutical composition
US6586483B2 (en) 2001-01-08 2003-07-01 3M Innovative Properties Company Foam including surface-modified nanoparticles
CN1263808C (zh) * 2001-02-27 2006-07-12 清华大学 一种微米颗粒表面纳米化改性方法
DE60222160T2 (de) * 2001-10-12 2008-06-12 Elan Pharma International Ltd., Athlone Zusammensetzungen mit einer kombination aus eigenschaften sofortiger freisetzung und kontrollierter freisetzung
US7923030B2 (en) * 2003-03-14 2011-04-12 Sol-Gel Technologies, Inc. Agent-encapsulating micro- and nanoparticles, methods for preparation of same and products containing same
US7459146B2 (en) * 2003-05-30 2008-12-02 3M Innovative Properties Company Stabilized aerosol dispersions

Similar Documents

Publication Publication Date Title
Weers et al. Formulation design of dry powders for inhalation
JP2013542940A5 (enExample)
HRP20210704T1 (hr) Formulacija suhog praška koja sadrži antikolinergik, kortikosteroid i beta-adrenergik za davanje inhalacijom
RU2010141331A (ru) Новая доза и препаративная форма
JP2009512663A5 (enExample)
JP2013224331A5 (enExample)
JP2012517987A5 (ja) 吸入用の医薬組成物のｆｐｄ特性を設定する方法
RU2010141333A (ru) Новая доза и препаративная форма
JP2014528470A5 (enExample)
JP2011520911A5 (enExample)
JP2006526624A5 (enExample)
JP2015519356A5 (enExample)
JP2002538110A5 (enExample)
HK1203149A1 (en) Novel dosage form and formulation of abediterol
AR067639A1 (es) Medicamentos pulverulentos que contienen tiotropio y salmetrol, asi como lactosa como excipiente
JP2005502675A5 (enExample)
UA107499C2 (uk) Склад сухого порошку, який містить антимускариновий засіб
WO2008084312A3 (en) Micronised particles of low-dosage strength active agents for powder formulations for inhalation
JP2013531056A5 (enExample)
JP2014530231A5 (enExample)
MY159172A (en) Inhalable particles comprising tiotropium
WO2006008517A3 (en) Use of dry powder compositions for pulmonary delivery
JP2007520507A5 (enExample)
CA3199912A1 (en) Luminol for the prophylaxis and the treatment of sequelae of a sars-cov-2 infection
MY187442A (en) A pharmaceutical composition containing budesonide and formoterol